A 13-year-old male patient presented with a primary complaint of reduced vision in both eyes for the past 15 days at LV ...

Researchers from Children's Hospital of Philadelphia (CHOP) have discovered the underlying biology that identifies a subset ...

An expert highlighted unmet needs in treating T-cell acute lymphoblastic leukemia and where research may focus in the future.

A novel CAR T-cell therapy has benefitted patients with relapsed acute lymphoblastic leukemia, showing high response rates in ...

In a recent study published in Nature Cancer, researchers explore treatment resistance and relapse in T-cell acute ...

Immunotherapies have shaped the cancer research space over the past decade, proving effective for the treatment of some ...

A newly approved immunotherapy can help adults with a difficult-to-treat form of leukemia, clinical trial results show.

Researchers have discovered the underlying biology that identifies a subset of patients with acute lymphoblastic leukemia who ...

Adoptive cell transfer with chimeric antigen receptor (CAR)-expressing T cells can induce remarkable complete responses in ...

Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel anti-CD19 chimeric antigen receptor (CAR) T cell therapy, obecabtagene ...

ALL, certain drugs work for some patients who relapse, but these drugs are not effective for all patients who relapse.